Financial Planning & Information Services Inc. reduced its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 19.5% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,145 shares of the company’s stock after selling 521 shares during the […]
Venturi Wealth Management LLC decreased its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 12.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,718 shares of the company’s stock after selling 945 shares during the quarter. Venturi Wealth […]
Lipe & Dalton lowered its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,010 shares of the company’s stock after selling 1,499 shares during the quarter. AbbVie comprises about 3.7% of Lipe […]
Lineweaver Wealth Advisors LLC lifted its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 4.7% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 2,338 shares of the company’s stock after buying an additional 106 shares during the quarter. Lineweaver Wealth Advisors […]
Lipe & Dalton trimmed its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,010 shares of the company’s stock after selling 1,499 shares during the quarter. AbbVie accounts for 3.7% of […]